Skip to main content Skip to section navigation Skip to footer
Aethlon Medical, Inc. Corporate Home
  • The Hemopurifier®
    • Overview
    • The Hemopurifier® in Cancer
    • The Hemopurifier® in Infectious Disease
  • About
    • Overview
    • Leadership
    • Board of Directors
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Publications
    • Training Videos
  • Investors
    • Overview
    • Corporate News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Analyst Coverage
  • Contact Us
News & Media
  • Press Releases
  • Presentations
  • Events
  • Publications
  • Training Videos

Press Releases

Mar 4, 2015

Aethlon Medical to Present at the 27th Annual ROTH Conference

Feb 26, 2015

Aethlon Medical Announces First Patient Completes Hemopurifier® Clinical Study Protocol

Feb 24, 2015

Aethlon Medical, Inc. - CTE Data Presentation at the Upcoming 2015 TBI Conference

Feb 12, 2015

Aethlon Medical, Inc. - A Publication Describing the First Treatment of Ebola with the Aethlon Hemopurifier®

Feb 5, 2015

Aethlon Medical, Inc. - The Launch of a Clinical Program That Re-Thinks the Treatment of Viral Pathogens

Jan 8, 2015

Aethlon Medical to Present at Biotech Showcase 2015

Jan 2, 2015

Aethlon Medical Announces Approval of Ebola Treatment Protocol

Dec 11, 2014

Aethlon Medical Initiates Patient Recruitment for FDA Approved Clinical Study

Dec 2, 2014

Aethlon Medical® Reports Rapid and Sustained Virologic Response Rates in Hepatitis C (HCV) Treated Patients

Nov 26, 2014

Aethlon Medical Announces $3.3 Million Equity Investment

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Next Pagearrow_forward
rss_feed News RSS
Linkedin
Privacy Policy Disclaimer Sitemap Accessibility Statement
©2025 Aethlon Medical, Inc. All Rights Reserved.